TEVA · Teva Pharmaceutical Industries Ltd · Fails to Deliver
$43.65
+0.41 (+0.95%)
At close · Nov 12
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$50.93B
Shares
1.17B
Volume · Nov 12
9.25M
Avg daily vol (3M)
6.03M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-13 | 1,209 | $41.17 | $49,775 |
| 2026-10-09 | 6 | $39.25 | $236 |
| 2026-10-06 | 189 | $39.66 | $7,496 |
| 2026-10-05 | 50 | $39.53 | $1,977 |
| 2026-10-02 | 50 | $39.31 | $1,966 |
| 2026-09-30 | 50 | $39.81 | $1,991 |
| 2026-09-25 | 443,776 | $40.22 | $17,848,671 |
| 2026-09-24 | 45,509 | $39.01 | $1,775,306 |
| 2026-09-23 | 844 | $39.52 | $33,355 |
| 2026-09-22 | 18,519 | $40.06 | $741,871 |
| 2026-09-21 | 3,768 | $38.98 | $146,877 |
| 2026-09-18 | 183 | $39.19 | $7,172 |
| 2026-09-17 | 5,673 | $38.53 | $218,581 |
| 2026-09-16 | 5,371 | $39.25 | $210,812 |
| 2026-09-15 | 201,448 | $38.72 | $7,800,067 |
| 2026-09-14 | 12,764 | $37.09 | $473,417 |
| 2026-09-09 | 364 | $36.76 | $13,381 |
| 2026-09-04 | 66 | $36.62 | $2,417 |
| 2026-09-02 | 144 | $36.19 | $5,211 |
| 2026-09-01 | 1,611 | $36.05 | $58,077 |
| 2026-08-26 | 7,094 | $38.10 | $270,281 |
| 2026-08-24 | 142,931 | $37.34 | $5,337,044 |
| 2026-08-21 | 8,026 | $36.81 | $295,437 |
| 2026-08-19 | 156 | $36.58 | $5,706 |
| 2026-08-18 | 780 | $36.46 | $28,439 |
| 2026-08-17 | 96 | $36.77 | $3,530 |
Showing 1–26 of 26 settlements
Key facts
CIK
818686
CUSIP
M8769Q102
13F (30d)
437 filings
389 filers
Visit website
Investor relations